Quadcap Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Sell
726
-31
-4% -$11.1K 0.03% 333
2025
Q4
$248K Sell
757
-103
-12% -$32.7K 0.03% 347
2025
Q3
$243K Sell
860
-21
-2% -$6.09K 0.03% 355
2025
Q2
$246K Buy
881
+22
+3% +$6.23K 0.03% 344
2025
Q1
$268K Buy
859
+29
+3% +$8.56K 0.04% 318
2024
Q4
$216K Sell
830
-22
-3% -$6.53K 0.03% 351
2024
Q3
$275K Buy
+852
New +$279K 0.04% 320
2024
Q2
Sell
-704
Closed -$200K 384
2024
Q1
$200K Sell
704
-17
-2% -$4.97K 0.05% 318
2023
Q4
$208K Buy
+721
New +$196K 0.05% 310

Other funds holding AMGN

Quadcap Wealth Management's AMGN Position: Q1 2026 in Review

Quadcap Wealth Management reduced its Amgen (AMGN) stake by 4.1% in Q1 2026, selling an estimated $11.1K and leaving 726 shares worth $255K. The position accounts for 0.03% of the portfolio, ranked #333.

Quadcap Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $275K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Quadcap Wealth Management held 726 shares of Amgen worth $255K as of Q1 2026.
  • Quadcap Wealth Management sold 31 Amgen shares in Q1 2026, an estimated $11.1K.
  • Amgen made up 0.03% of Quadcap Wealth Management's portfolio in Q1 2026, its #333 holding.
  • Quadcap Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
  • Quadcap Wealth Management's Amgen position peaked at $275K in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.